EZCase to debut in spring 2015

Article

WatchDog Group will debut EZCase, contact lens case packed with features to help prevent microbial contamination, at food, drug, and major retailers in spring 2015.

St. Louis, MO-WatchDog Group will debut EZCase, contact lens case packed with features to help prevent microbial contamination, at food, drug, and major retailers in spring 2015.

EZcase uses patent-pending, flip-top design making it easy to open and close. Left and right solution soaking wells are clearly marked. The new flip-top drying feature keeps solution wells from touching dangerous sink top bacteria while also keeping allergy dust and bathroom particles from dropping into the wells.

The harsh reality of contact lens care compliance

“We’ve seen countless health innovations in contact lenses since soft, extended wear contacts were introduced in 1981, but the plastic case to soak and disinfect them overnight has never significantly changed,” says head designer John O’Hara. 

The new flip-top design takes FDA contact lens case warnings about frequent replacement and the dangers of water and molds them into the case. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.